Cryo Cell International (CCEL) Amortization of Deferred Charges (2017 - 2026)

Cryo Cell International has disclosed Amortization of Deferred Charges across 10 years of filings, most recently posting $5136.0 for Q1 2026.

• In Q1 2026, Amortization of Deferred Charges fell 2.1% year-over-year to $5136.0; the TTM figure through Feb 2026 stood at $20712.0 (down 2.0% YoY), while the FY2025 annual figure was $20822.0, down 1.95% from the prior year.
• Amortization of Deferred Charges slipped to $5136.0 in Q1 2026, from $5165.0 in the prior quarter.
• Over the last five years, Amortization of Deferred Charges for CCEL reached as high as $6389.0 in Q1 2022 and fell as low as $591.0 in Q3 2022.
• The 5-year median for Amortization of Deferred Charges is $5298.0 (2024), against an average of $4980.0.
• Annual changes were most pronounced in 2022 — Amortization of Deferred Charges sank 95.23% — and 2023, when it soared 813.2%.
• A 5-year view of Amortization of Deferred Charges shows it stood at $5466.0 in 2022, then dropped by 1.72% to $5372.0 in 2023, then retreated by 1.9% to $5270.0 in 2024, then fell by 1.99% to $5165.0 in 2025, then slipped by 0.56% to $5136.0 in 2026.
• According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $5136.0, $5165.0, and $5192.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.